Skip to content

The Drug Information and Monitoring System (DIMS) in the Netherlands: implementation, results, and international comparison.

Tibor M Brunt, Raymond J.m. Niesink

Drug Testing and Analysis September 2011 DOI: 10.1002/dta.323 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Population Illicit drug samples submitted at DIMS testing facilities in the Netherlands
Key findings The review describes the Drug Information and Monitoring System (DIMS), which has collected more than 100,000 illicit drug samples over nearly two decades to prevent health hazards from unexpected substances. It overviews monitoring results for ecstasy, amphetamine, and cocaine markets, and for the first time hallucinogens, and discusses drug monitoring from policy, prevention, and user perspectives.

Abstract

The Ministry of Health in the Netherlands has made illicit drug testing for drug users possible since the 1990s, in order to prevent serious health hazards associated with unexpected dangerous substances. This system of illicit drug testing is called the Drug Information and Monitoring System (DIMS). In nearly two decades, more than 100 000 drug samples have been handed in at DIMS testing facilities. This review describes the DIMS methodology and overviews results of the three main psychostimulant drug markets that have been monitored, i.e. ecstasy, amphetamine (speed), and cocaine. Additionally, monitoring results of hallucinogens are also described for the first time. For comparison, alternative international monitoring systems are described briefly alongside some of their results. Finally, drug monitoring is discussed from the perspectives of policy, prevention, and the drug users themselves.

Citations in the library

Cited by 19

and 14 more in the library

Cites 10

and 5 more in the library

Explore topics